Concord Drugs Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹12.37Cr |
Net Profits | ₹0.04Cr |
Net Profit Margins | 0.32% |
Highlights
Revenue:
Concord Drugs Ltd’s revenue jumped 64.49% since last year same period to ₹12.37Cr in the Q2 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 5.82% jump in its revenue since last 3-months.
Net Profits:
Concord Drugs Ltd’s net profit fell -92.86% since last year same period to ₹0.04Cr in the Q2 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 33.33% jump in its net profits since last 3-months.
Net Profit Margins:
Concord Drugs Ltd’s net profit margin fell -95.66% since last year same period to 0.32% in the Q2 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 26% jump in its net profit margins since last 3-months.
